The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials Jochen Schmitt, MD, Phyllis I. Spuls, MD, PhD, Kim S. Thomas, PhD, Eric Simpson, MD, Masutaka Furue, MD, Stefanie Deckert, MPH, Magdalene Dohil, MD, Christian Apfelbacher, PhD, Jasvinder A. Singh, MD, Joanne Chalmers, PhD, Hywel C. Williams, DSc Journal of Allergy and Clinical Immunology Volume 134, Issue 4, Pages 800-807 (October 2014) DOI: 10.1016/j.jaci.2014.07.043 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 HOME roadmap to identify adequate instruments to measure a specific core domain for AE trials. Core outcome domains are as follows: (1) clinical signs, (2) symptoms, (3) quality of life, and (4) long-term control of flares. Journal of Allergy and Clinical Immunology 2014 134, 800-807DOI: (10.1016/j.jaci.2014.07.043) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions